Menu Search
Equities

China Healthwise Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
348:HKG.HS

China Healthwise Holdings Ltd

Actions
  • Price (HKD)0.139
  • Today's Change0.00 / 0.00%
  • Shares traded120.00k
  • 1 Year change-17.26%
  • Beta0.3276
Data delayed at least 15 minutes, as of Feb 11 2026 08:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

China Healthwise Holdings Ltd is an investment holding company mainly engaged in the Chinese health products business. The Company operates its business through three segments. The Chinese Health Products segment is mainly engaged in the sale of Chinese health products business. The Money Lending Business segment is mainly engaged in the granting loans business. The Investment in Financial Instruments segment is mainly engaged in investing in financial instruments.

  • Revenue in HKD (TTM)103.70m
  • Net income in HKD-10.20m
  • Incorporated--
  • Employees77.00
  • Location
    China Healthwise Holdings LtdLung Cheong Building1 Lok Yip Road, FanlingNew Territories Hong KongHKG
  • Phone+852 22688248
  • Fax+852 25485575
  • Websitehttps://www.healthwisehk.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.